Building Blocks
Esta seção contém produtos fundamentais para a síntese de compostos orgânicos e biológicos. Building blocks são os materiais de partida essenciais usados para construir moléculas complexas através de várias reações químicas. Eles desempenham um papel crítico na descoberta de medicamentos, ciência dos materiais e pesquisa química. Na CymitQuimica, oferecemos uma ampla gama de building blocks de alta qualidade para apoiar suas pesquisas inovadoras e projetos industriais, garantindo que você tenha os componentes essenciais para uma síntese bem-sucedida.
Subcategorias de "Building Blocks"
- Ácidos Borónicos e Derivados de Ácido Borónico(5.778 produtos)
- Building Blocks Quirais(1.243 produtos)
- Building Blocks Hidrocarbonetos(6.097 produtos)
- Building Blocks orgânicos(61.048 produtos)
Foram encontrados 203115 produtos de "Building Blocks"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
tert-Butyl N-[2-(1-hydroxyethyl)-3-methoxyphenyl]carbamate
CAS:Versatile small molecule scaffoldFórmula:C14H21NO4Pureza:Min. 95%Peso molecular:267.32 g/mol1-(Pyridin-2-yl)piperidin-4-amine dihydrochloride
CAS:Versatile small molecule scaffoldFórmula:C10H15N3·2HClPureza:Min. 95%Peso molecular:250.17 g/molcyclopentanecarboxamide
CAS:<p>Cyclopentanecarboxamide is a class of organic compounds that are used as antihypertensives, immunosuppressants, and antineoplastic agents. The compound is a potent adenosine receptor antagonist and has been shown to inhibit the production of chemokines in cultured cells. Cyclopentanecarboxamide also inhibits the activation of hydrogen bond-dependent enzymes such as fatty acid synthase and lipoxygenase. This inhibition leads to an anti-inflammatory effect by reducing inflammation caused by these enzymes. Cyclopentanecarboxamide also has been shown to reduce the incidence of myocardial infarcts in rats when given before or after coronary artery ligation.</p>Fórmula:C6H8N2OPureza:Min. 95%Peso molecular:124.14 g/mol5-(Methoxymethyl)pyridine-3-carboxylic acid
CAS:Versatile small molecule scaffoldFórmula:C8H9NO3Pureza:Min. 95%Peso molecular:167.16 g/mol3-[(3-Fluorophenyl)methyl]pyrrolidine
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C11H14FNPureza:Min. 95%Peso molecular:179.23 g/mol3-[4-(Trifluoromethyl)phenyl]pyrrolidine
CAS:Versatile small molecule scaffoldFórmula:C11H12F3NPureza:Min. 95%Peso molecular:215.22 g/molBenzothiophene-4-boronic acid pinacol ester
CAS:Versatile small molecule scaffoldFórmula:C14H17BO2SPureza:Min. 95%Peso molecular:260.16 g/mol2-Benzyl-1,2,6-thiadiazinane 1,1-dioxide
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H14N2O2SPureza:Min. 95%Peso molecular:226.29 g/mol3-(3,6-Dihydro-2H-pyran-4-yl)benzoic acid
CAS:Versatile small molecule scaffoldFórmula:C12H12O3Pureza:Min. 95%Peso molecular:204.22 g/mol2-Bromoquinoline-3-carbonitrile
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H5BrN2Pureza:Min. 95%Peso molecular:233.06 g/mol2-(5-Methylfuran-2-yl)propanoic acid
CAS:Versatile small molecule scaffoldFórmula:C8H10O3Pureza:Min. 95%Peso molecular:154.16 g/mol1-(3-Bromophenyl)-1H-1,2,4-triazole
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H6BrN3Pureza:Min. 95%Peso molecular:224.06 g/molMethyl imidazo[1,2-a]pyrimidine-7-carboxylate
CAS:Versatile small molecule scaffoldFórmula:C8H7N3O2Pureza:Min. 95%Peso molecular:177.16 g/mol7-Methoxyimidazo[1,2-a]pyrimidine
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C7H7N3OPureza:Min. 95%Peso molecular:149.15 g/mol4-[(3-Amino-4-bromo-1H-pyrazol-1-yl)methyl]benzohydrazide
CAS:Versatile small molecule scaffoldFórmula:C11H12BrN5OPureza:Min. 95%Peso molecular:310.15 g/mol(1R,2S)-2-(Aminomethyl)cyclohexan-1-ol hydrochloride
CAS:Versatile small molecule scaffoldFórmula:C7H16ClNOPureza:Min. 95%Peso molecular:165.66 g/mol5-{2-[(2-Bromophenyl)methylidene]hydrazin-1-yl}-2-chlorobenzoic acid
CAS:Versatile small molecule scaffoldFórmula:C14H10BrClN2O2Pureza:Min. 95%Peso molecular:353.6 g/mol1-Amino-5-phenylpentan-3-ol
CAS:<p>1-Amino-5-phenylpentan-3-ol is a drug that is used in the treatment of epilepsy and neurodegenerative diseases. It is an antagonist for the amino acid glutamate, which may be involved in the development of seizures and neurodegeneration. The compound has two enantiomers, which are called S(+) and R(−). The S(+) form has been shown to be more potent than the R(−) form. 1-Amino-5-phenylpentan-3-ol binds to the glutamate receptor on neurons, blocking the binding of glutamate and inhibiting its excitatory effects. This drug also has a diastereomeric effect, with one stereoisomer having a right hand twist and the other left hand twist.</p>Fórmula:C11H17NOPureza:Min. 95%Peso molecular:179.26 g/mol2-Methyl-2-(morpholin-4-yl)propanoic acid hydrochloride
CAS:Versatile small molecule scaffoldFórmula:C8H16ClNO3Pureza:Min. 95%Peso molecular:209.67 g/molMethyl 5-oxo-5,6,7,8-tetrahydroquinoline-6-carboxylate
CAS:Versatile small molecule scaffoldFórmula:C11H11NO3Pureza:Min. 95%Peso molecular:205.21 g/mol
